posted on Jul, 8 2021 @ 10:31 PM
It's happening, the 3 rd jab is on its way.
US Pfizer of Michael Dorsten Chief Scientific Officer is 8 days, the company has developed with Germany Biontekku new corona virus for vaccine, within
the next month the authorization of additional third vaccination (booster vaccination) He said he would apply to the US Food and Drug Administration
(FDA). The reason is that there is evidence that the risk of reinfection increases six months after the second inoculation, and that the highly
infectious mutant strain (Delta strain) derived from India has spread. Dorsten explained that there were recent reports in Israel that the vaccine was
less effective because people who had been vaccinated mainly in January or February were re-infected. The Israeli Ministry of Health announced that
the infection and onset prevention effects of Pfizer vaccines in June were both reduced to 64%. "Pfizer's vaccine is also highly effective against
Delta strains," he said, but admitted six months after vaccination that "antibodies weaken as expected, which could pose a risk of reinfection."
Pfizer did not disclose all Israeli vaccine data on the 8th, but said it would be released soon. Dorsten emphasized that even with lower antibody
levels, vaccines that prevent aggravation continue to be around 95% effective, based on data from Israel and the United Kingdom. In addition,
Pfizer's own research added that three doses of antibody levels jumped 5-10 times higher than those of two doses, suggesting the expected effects.
Several countries, including Europe, have already consulted Pfizer for a third vaccination, and additional vaccinations may begin somewhere before it
is approved in the United States.
It might be in Japanese.